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Background: The mesolimbic dopamine system, composed primarily of dopaminergic neurons in the ventral tegmental area that project to stria-
tal structures, is considered to be the key mediator of reinforcement-related mechanisms in the brain. Prompted by a genome-wide association 
meta-analysis implicating the Ras-specific guanine nucleotide-releasing factor 2 (RASGRF2) gene in the regulation of alcohol intake in men, we 
have recently shown that male Rasgrf2–/– mice exhibit reduced ethanol intake and preference accompanied by a perturbed mesolimbic dopa-
mine system. We therefore propose that these mice represent a valid model to further elucidate the precise genes and mechanisms regulating 
mesolimbic dopamine functioning. Methods: Transcriptomic data from the nucleus accumbens (NAcc) of male Rasgrf2–/– mice and wild-type 
controls were analyzed by weighted gene coexpression network analysis (WGCNA). We performed follow-up genetic association tests in hu-
mans using a sample of male adolescents from the IMAGEN study characterized for binge drinking (n = 905) and ventral striatal activation during 
an fMRI reward task (n = 608). Results: The WGCNA analyses using accumbal transcriptomic data revealed 37 distinct “modules,” or function-
ally related groups of genes. Two of these modules were significantly associated with Rasgrf2 knockout status: M5 (p < 0.001) and M6 (p < 
0.001). In follow-up translational analyses we found that human orthologues for the M5 module were significantly (p < 0.01) enriched with genetic 
association signals for binge drinking in male adolescents. Furthermore, the most significant locus, originating from the EH-domain containing 4 
(EHD4) gene (p < 0.001), was also significantly associated with altered ventral striatal activity in male adolescents performing an fMRI reward 
task (pempirical < 0.001). Limitations: It was not possible to determine the extent to which the M5 module was dysregulated in Rasgrf2–/– mice by 
perturbed mesolimbic dopamine signalling or by the loss of Rasgrf2 function in the NAcc. Conclusion: Taken together, our findings indicate that 
the accumbal M5 module, initially identified as being dysregulated in male Rasgrf2–/– mice, is also relevant for human alcohol-related phenotypes 
potentially through the modulation of reinforcement mechanisms in the NAcc. We therefore propose that the genes comprising this module rep-
resent important candidates for further elucidation within the context of alcohol-related phenotypes.
Early-released on Dec. 15, 2015; subject to revision
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Introduction
Binge drinking is a major public health problem that is par­
ticu larly prevalent during adolescence.1 It constitutes an in­
creased risk of substance use in later life as well as mental 
health problems throughout the lifespan.2,3 Early onset of ex­
cessive drinking is one of the strongest predictors of a life­
time prevalence of alcohol dependence.4,5 The mesolimbic 
pathway, which consists primarily of dopaminergic neurons 
in the ventral tegmental area (VTA) that send projections to 
the nucleus accumbens (NAcc), is considered to be a central 
regulator of alcohol­related phenotypes.6 However, despite 
the apparent importance of the mesolimbic pathway within 
the context of alcohol, the specific genes and mechanisms in­
volved are not fully understood.
Large­scale genome­wide association studies (GWAS) have 
recently implicated several novel genes in the regulation of 
 alcohol­related phenotypes in multiple populations.7,8 The ex­
ploratory nature of GWAS is proving to be instrumental in fur­
thering our understanding of the precise mechanisms in the 
brain that regulate alcohol­related phenotypes, particularly 
when combined with extensive  follow­up functional work. In a 
recent GWAS meta­analysis of alcohol consumption (n > 
20  000) we identified a novel male­specific signal in the 
 RASGRF2 gene,9 and in further support of this, a follow­up 
 candidate­based analysis in a sample of male adolescents re­
vealed a significant association between a  RASGRF2 polymor­
phism and frequency of binge drinking episodes.10
RASGRF2 encodes a Ras­specific guanine nucleotide­ 
releasing factor that is widely expressed across human  tissues 
with particular enrichment in the brain, where expression ap­
pears to be neuron­specific.11 It is a Ca2+/calmodulin­regulated 
protein responsible for coupling N­methyl­d­ aspartate receptor 
(NMDA)–type and calcium­ permeable α­Amino­3­hydroxy­5­
methyl­4­isoxazolepropionic acid (AMPA)–type glutamate re­
ceptors to mitogen activated protein kinase (MAPK) signalling 
cascades, including the extracellular signal–regulated kinase 
(ERK) pathway.12,13 Moreover, via the ERK pathway Rasgrf2 has 
been shown to activate the cAMP­response element binding 
(CREB) protein while also promoting long­term potentiation 
(LTP) in the mouse hippocampus.14
We recently performed behavioural and neurobiological 
phenotyping of a Rasgrf2–/– mouse strain in order to validate 
and extend upon our GWAS signal implicating RASGRF2 in 
alcohol consumption.9 We found a significant reduction in 
both ethanol intake and preference in male (no significant dif­
ferences were found in female mice) Rasgrf2–/– mice relative to 
wild­type controls,10 which is in accordance with the male­
specific GWAS signal.9 Male Rasgrf2–/– mice also exhibited de­
creased mesolimbic dopamine neuron activity relative to con­
trols, which was accompanied by reduced ethanol­induced 
dopamine release in the NAcc.10 This blunted mesolimbic do­
pamine response to acute ethanol indicates that the mech­
anisms underlying ethanol reinforcement in the NAcc would 
either be absent or mitigated, thereby explaining the reduced 
ethanol intake and preference observed in mutant mice.
Male Rasgrf2–/– mice therefore represent a convincing model 
to further explore the precise mechanisms within the mesolim­
bic dopamine system responsible for mediating the reinforcing 
effects of alcohol. Considering these mechanisms are coordin­
ated by multiple (as opposed to single) genes, in the present 
study we applied a systems biology approach to transcriptome­
wide mRNA expression data from the NAcc of male Rasgrf2–/– 
mice and wild­type controls to investigate the downstream 
consequences of an altered mesolimbic dopamine system. We 
first used these data to construct a weighted gene coexpression 
network, from which we identified a group (or module) of 
functionally related genes associated with Rasgrf2 gene knock­
out (KO) status. We then validated the relevance of this module 
for human binge drinking and ventral striatal activation using a 
sample of adolescent boys from the IMAGEN project.15
Methods
Animal experiments
All procedures were carried out according to the UK Animals 
(Scientific Procedures) Act 1986, and ethics approval was 
granted by the King’s College London research ethics com­
mittee. In accordance with our previous article reporting sig­
nificantly reduced ethanol intake and preference in male 
 Rasgrf2–/– mice relative to wild­type controls, but not female 
mice,10 we investigated male mice only. All mice were born 
and weaned from multiple litters in the Santos laboratory at 
the University of Salamanca, Spain, where the Rasgrf2–/– strain 
is being maintained,11 and were then shipped to the UK, re­
maining in quarantine until they cleared a health screen. We 
used 8­ to 10­week­old wild­type and Rasgrf2–/– C57BL/6 
mice (9 per group), exclusively male, single­housed with free 
access to food and water.11 Artificial light was provided daily 
from 7 am to 7 pm (12 h light/dark cycle), and the room tem­
perature and humidity were kept constant (temperature: 22 + 
1° C; humidity: 55 + 5%).
Tissue preparation, RNA extraction and transcriptomic 
profiling 
We dissected the NAcc from animals and extracted total 
RNA using the RNeasy Micro Kit (QIAGEN). Total RNA was 
biotinylated and amplified using the Illumina TotalPrep 
RNA Amplification kit (Applied Biosystems), and transcrip­
tome profiling was performed using the Illumina Mouse 
WG­6 version 2.0 Expression BeadChip (Illumina) as per the 
manufacturer’s protocol.
Human genetic association studies
In accordance with our animal experiments, we used data ex­
clusively from male participants in our human genetic associ­
ation studies. All participants were from the IMAGEN study. 
A detailed description of recruitment and assessment proced­
ures, as well as inclusion and exclusion criteria, has previ­
ously been published.15 In brief, the IMAGEN study is a 
multi site European research project designed to investigate 
risk­taking behaviour in teenagers using a longitudinal de­
sign beginning at age 14 years with follow­up at ages 16 and 
18 years, with the collection of genetic, behavioural, neuro­
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psychological and neuroimaging data throughout. Partici­
pants were collected across 8 IMAGEN assessment centres 
(London and Nottingham in England; Dublin, Ireland; 
Mannheim, Berlin, Hamburg and Dresden in Germany; and 
Paris, France). Local ethics research committees at each site 
approved the study. On the day of testing, written informed 
consent was obtained from the parent or guardian and verbal 
assent was obtained from the adolescent.
Genetic data were available for a total of 907 male adoles­
cents of European origin from the baseline assessment of the 
IMAGEN sample (mean age 14.42 ± 0.41 [range 12.88–
16.04]  yr). Binge drinking data were not available for 2 of 
these participants, leaving a total sample of 905 boys for 
binge drinking analyses. The binge drinking phenotype was 
defined as a binary phenotype (i.e., 0 v. 1) using the 2007 
 European School Survey Project on Alcohol and Other Drugs 
(ESPAD) questionnaire,16 where 699 (77.24%) had no previ­
ous binge drinking episodes (0) and 206 (22.76%) had 1 or 
more previous binge drinking episodes (1). Neuroimaging 
analyses were performed using a subsample of the above­
mentioned 905 male adolescents consisting of 608 boys (mean 
age 14.41 ± 0.42 [range 12.73–16.04] yr) for whom fMRI data 
were also available. Of this subsample of 608 boys, 2 were 
lacking binge drinking data, 473 (78.05%) had no previous 
binge drinking episodes and 133 (21.95%) had at least 1 pre­
vious episode of binge drinking. These proportions of binge 
drinkers (1) versus non–binge drinkers (0) are highly com­
par able to the full sample.
Monetary incentive delay fMRI task
Our adapted version of the monetary incentive delay (MID) 
task consisted of 66 10­s trials. In each trial, participants were 
presented with 1 of 3 cue shapes (cue 250 ms) denoting 
whether a target (white square) would subsequently appear 
on the left or right side of the screen and whether 0, 2 or 
10 points could be won in that particular trial. After a vari­
able delay (4000–4500 ms) of fixation on a white crosshair, 
participants were instructed to respond by pressing the left 
or right button as soon as the target appeared. Feedback on 
whether and how many points were won during the trial 
was presented for 1450 ms after the response. A tracking al­
gorithm adjusted task difficulty (i.e., target duration varied 
between 100 ms and 300 ms) such that each participant suc­
cessfully responded on approximately 66% of trials. For each 
5 points won, the participant would receive 1 reward in the 
form of small chocolate candies. Only successfully trials were 
included in our analysis.
DNA extraction and genotyping 
DNA purification and genotyping were performed at the Cen­
tre National de Génotypage in Paris. DNA was extracted from 
whole blood samples (approximately 10 mL) preserved in BD 
Vacutainer EDTA tubes (Becton, Dickinson and Company) 
 using a Gentra Puregene Blood Kit (QIAGEN) according to the 
manufacturer’s instructions. Genotype information was col­
lected at 582 982 markers using the Illumina HumanHap610 
Genotyping BeadChip (Illumina). Details on quality control of 
genotype data are provided in Appendix 1, available at jpn.ca.
RNA extraction and gene expression profiling 
Total RNA was extracted from whole blood cells using the 
PAXgene Blood RNA Kit (QIAGEN). Following quality control, 
labelled complementary RNA (cRNA) was generated  using the 
Illumina TotalPrep RNA Amplification kit (Applied Biosys­
tems). Gene expression profiling was performed using Illumina 
HumanHT­12 version 4 Expression BeadChips (Illumina). 
 Expression data were normalized using the mloess method.
Statistical and bioinformatics analysis
Gene expression data processing 
Raw intensity values were normalized by variance stabilization 
and quantile normalization using the Lumi Biocondcutor pack­
age.17 To reduce noise, probes not expressed above the back­
ground (p < 0.01) and low varying probes estimated with coeffi­
cient of variation (CV < 0.01) were removed from subsequent 
analysis. The probe with the highest mean expression value was 
selected from multiple probes representing the same gene.
Mouse gene coexpression network analysis and module 
characterization 
To identify modules (or groups) of functionally related genes 
within our mouse transcriptomic data, we applied weighted 
gene coexpression network analysis (WGCNA) as previously 
described.18,19 For further information on these analyses and 
the methods used to characterize and prioritize modules for 
follow­up studies, refer to Appendix 1.
Module-based GWAS signal enrichment analysis 
We used the efficient mixed­model association eXpedited 
(EMMAX) software program to run the genome­wide associ­
ation analysis for binge drinking.20 Further details are pro­
vided in Appendix 1.
Functional MRI data analysis 
Functional MRI data were analyzed using SPM8 (www.fil 
.ion.ucl.ac.uk/spm). Slice­time correction was conducted to 
adjust for time differences due to multislice imaging acquisi­
tion; all volumes were aligned to the first volume, and non­
linear warping was performed to an echo­planar imaging 
template. Images were then smoothed with a 5 mm full­
width at half­maximum Gaussian kernel.
At the first level of analysis, changes in the blood oxygen 
level–dependent (BOLD) response for each participant were 
 assessed using linear combinations at the individual level; for 
each experimental condition, each trial (i.e., reward anticipation 
high gain, reward feedback) was convolved with the hemo­
dynamic response function to form regressors that accounted 
for potential noise variance associated with the processing 
of reward anticipation. Estimated movement  parameters were 
added to the design matrix in the form of 18  additional 
 columns (3 translations, 3 rotations, 3 quadratic and 3 cubic 
translations, and each 3 translations with a shift of ± 1 repeti­
tion time). Single­participant contrast images were normalized 
to Montreal Neurological Institute (MNI) space. These normal­
ized and smoothed images were then taken to a second­level 
random effects analysis. The left and right ventral striatal (VS) 
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regions of interest (ROI) were  extracted  using the MarsBaR 
toolbox (http://marsbar .sourceforge.net) from the anticipation 
high gain versus no gain contrast as well as from the feedback 
high gain versus no gain contrast. The extracted ROIs were 
based on the study by O’Doherty and colleagues21 (MNI co­
ordinates: x, y, z = ±15, –9, 9; radius = 9 mm).
Establishment of linkage disequilibrium structures 
We used Haploview 4.2 software to define the haplotype 
blocks of the EHD4 gene.22 We selected the haplotype block 3 
for further analyses, where the candidate single nucleotide 
polymorphism (SNP) rs1648821 is located and the minimum 
pairwise linkage disequilibrium (LD), measured as D’, is 
higher than 0.99. We used Plink software to generate the hap­
lotype phases for each individual and performed the associa­
tion analyses.23
Kernel-based association measure
We used the kernel generalized variance24 to quantify the de­
pendence between the EHD4 SNPs and both binge drinking 
behaviour and fMRI BOLD response in the IMAGEN sample. 
Statistical inference was based on a permutation procedure 
where both a parametric approximation of the p value and an 
empirical p value were calculated; we report the latter in this 
article. For more details on the kernel­based association meas­
ure, refer to Appendix 1 and the study by Bach and Jordan.25
Results
Construction of a gene coexpression network
We began by constructing a coexpression network based on 
NAcc transcriptomic data derived from 9 male Rasgrf2–/– mice 
and 9 male wild­type controls (total n = 18) by applying 
WGCNA.18 This analysis revealed 37 groups, or modules, of 
genes that exhibited highly significant coexpression patterns 
from a total of 12 043 unique genes (Appendix 1, Fig. S1). The 
number of genes in a module varied widely from 39 to 3706.
Identification and characterization of coexpression  modules 
associated with KO status
To determine whether any of the identified coexpression 
modules were associated with KO status (binomial trait), 
we correlated each module with KO status using Pearson r 
with module eigengenes (i.e., the first principal component 
of the standardized gene expression profile of each mod­
ule). After Bonferroni correction for 37 modules, we found 
that 2 modules, modules 5 (M5; puncorrected < 0.001, pcorrected < 
0.001) and 6 (M6; puncorrected < 0.001, pcorrected = 0.025), were sig­
nificantly correlated with KO status (Fig. 1A). In order to 
provide validation, we also correlated these 2 modules with 
Rasgrf2 mRNA expression levels (quantitative trait). We 
found a significant correlation with the M5 module 
(Fig. 1B), which comprises 367 highly interconnected genes, 
but not with the M6 module (Fig. 1C). Specifically, the M5 
module eigengene in Rasgrf2-/- mice was reduced compared 
with wild­type controls, indicating that the majority of the 
genes in this module were downregulated in Rasgrf2-/- mice 
(Appendix 1, Fig. S2). We therefore took the M5 module for­
ward for further characterization.
At the individual gene level, more than 96% of genes in M5 
were differentially expressed significantly between Rasgrf2-/- 
mice and wild­type controls, with positive correlations evi­
dent between numerous M5 genes and Rasgrf2 expression 
levels. The top 40 genes (ranked by module membership) 
and their correlation with Rasgrf2 expression levels (r > 0.50), 
differentially expressed genes significantly between Rasgrf2-/- 
mice and wild­type controls (pFDR < 0.05), and the number of 
connections (> 50) with other genes in the module are pre­
sented in Table 1. A complete list of genes comprising the M5 
module can be found in Appendix 1, Table S1.
To begin to characterize the M5 module, we first per­
formed gene ontology (GO) term enrichment analysis. This 
revealed significant enrichment of M5 genes for protein 
phosphorylation and kinase activity, transferase and nucle­
ase activities and (cytoskeletal) protein binding in both the 
cytoplasm and nucleus (Appendix 1, Table S2). To determine 
whether the M5 module functions in a cell­specific manner, 
we tested whether M5 gene expression significantly overlaps 
with markers of the 4 major central nervous system (CNS) 
cell classes (astrocytes, microglia, neurons and oligodendro­
cytes). We found significant enrichment with neuronal 
marker genes (pcorr = 0.018; Appendix 1, Table S3), suggesting 
that M5 module functioning is neuron­specific.
The M5 module is enriched with alcohol-related genes 
in mice and humans
Because the M5 module was correlated with both KO status 
(binomial trait) and Rasgrf2 mRNA expression levels (quanti­
tative trait), we took this module forward to determine its rel­
evance for alcohol­related phenotypes. We first set out to de­
termine to what extent M5 module genes overlap with 
previously identified quantitative trait loci (QTL) for alcohol 
preference in mice.26 We identified a total of 36 M5 genes lo­
cated within these QTL, including Adamtsl2, Atm, Cryab, 
Neo1, Pgm2 and Rasl12 (Appendix 1, Table S4), indicating that 
the M5 module does contain genes already implicated in the 
regulation of alcohol preference.
We then shifted our focus to human alcohol­related pheno­
types by investigating whether human orthologues to M5 mod­
ule genes are enriched with genetic association signals for binge 
drinking in a sample of 905 14­year­old adolescent males from 
the IMAGEN project.15 We identified 250 human orthologues 
for M5 module genes, 216 of which contained SNPs covered by 
the Illumina HumanHap610 Genotyping BeadChip (see Table 1 
for orthologues of the top 40 M5 genes). This set of 216 ortho­
logues was significantly enriched with genetic association sig­
nals for binge drinking GWAS data, even after correction for 
multiple testing (p = 0.01, pFDR = 0.02; Fig. 2A).
In order to filter this list of orthologues to identify the most 
prominent candidates for involvement in alcohol­related 
phenotypes, we revisited our mouse coexpression data and 
preferentially selected genes that exhibited a high module 
membership (MM > 0.5) and a highly significant correlation 
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with Rasgrf2 mRNA expression (p < 0.01). Thus, of the initial 
set of 216 human genes, we highlighted 28 candidates for 
 alcohol­related phenotypes based on the apparent promi­
nence of their orthologues in the M5 module  (Table 2).
EHD4 is associated with binge drinking and VS activation 
during a reward task
The SNP showing the most highly significant association 
with binge drinking was rs1648821 (p < 0.001), which is lo­
cated in intron 3 of the EH­domain containing 4 (EHD4) 
gene (Fig. 2B and Appendix 1, Table S5). In order to further 
validate our overall findings, we decided to take EHD4 for­
ward for candidate­based analyses. First, we extended upon 
the single SNP association between rs1648821 and binge 
drinking by performing a haplotype analysis in the same 
sample of male adolescents.15 We selected haplotype block 
3, which consists of rs1648821 and 5 other SNPs (Appendix 
1, Fig. S3 and Table S5), to test for a kernel­based associa­
tion with binge drinking behaviour. This yielded a highly 
significant result (pempirical < 0.001; all empirical p values pre­
sented in this study are based on 1000 permutations).
We have previously shown that RASGRF2 appears to  exert 
its effect on alcohol­related phenotypes by altering mesolimbic 
dopamine function, resulting in a mitigation of the rewarding 
effects of alcohol.10 Thus, to determine whether EHD4 might 
exert its effect on binge drinking through similar mechanisms, 
we examined whether there was an association between hap­
lotype block 3 in EHD4 and activation of the VS, which con­
tains the NAcc, during a  reward task (i.e., the MID task). Our 
sample consisted of 608 14­year­old boys from the IMAGEN 
baseline assessment with fMRI data, which was a subsample 
the study’s 905 participants.15 Whole brain contrast maps dur­
ing reward anticipation showed a widespread positive BOLD 
Fig. 1: Identifying gene coexpression modules associated with knockout (KO) status. (A) Association of each module’s eigengene with the KO 
status. The Y  axis indicates the –log10 of the association p value. The dotted red line represents the significance level at p < 0.001 after 
 Bonferroni correction. (B, C) Correlations between gene significance (i.e., correlation with Rasgrf2 gene expression levels) and module mem-
bership for (B) M5 and (C) M6 modules. Colour-coding is equivalent to module names (green and medium purple).
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response, with highest activation in subcortical regions, includ­
ing the VS, extending into the insula, prefrontal cortex and the 
parietal cortex (Fig. 3A). Reward feedback induced significant 
positive BOLD responses predominantly in the cingulate 
 gyrus, the prefrontal cortex and the parietal cortex (Fig. 3B). In 
the anticipation phase, we found a significant association be­
tween haplotype block 3 in EHD4 and the right (pempirical < 0.001) 
but not the left VS  (pempirical = 0.41;  Appendix 1, Table S6). There 
was no significant association between haplotype block 3 and 
VS activity upon reward feedback (data not shown).
Evidence of a cis-acting haplotypic effect on EHD4 mRNA 
expression
Considering rs1648821 and the other 5 SNPs constituting hap­
lotype block 3 are all intronic and do not tag (r2 > 0.8) any 
 coding SNPs, we set out to test whether this haplotype influ­
enced EHD4 mRNA expression levels. EHD4 expression data 
from peripheral blood were available from a subsample of ado­
lescent boys (n = 190) from the IMAGEN project. By applying a 
kernel­based association test, we found an association between 
Table 1: Top 40 M5 module genes ranked by module membership. Differential gene expression between wild-type and 
Rasgrf2–/– mice and module membership statistics, as well as human orthologues, are also included. 
Rank Mouse gene symbol
Differential expression Module membership
Human gene 
symbollogFC t p value MM p value kWithin
1 Glrx1 3 38.27 < 0.001 0.99 < 0.001 76.61 —
2 LOC666403 4.48 59.71 < 0.001 0.99 < 0.001 76.23 —
3 1200015F23Rik 2.15 42.63 < 0.001 0.99 < 0.001 75.97 —
4 Tmem87a –2.38 –42.17 < 0.001 –0.99 < 0.001 75.47 TMEM87A
5 Lrrc57 2.44 34.6 < 0.001 0.99 < 0.001 75.23 LRRC57
6 Ccndbp1 1.43 24.13 < 0.001 0.99 < 0.001 73.6 CCNDBP1
7 9930021D14Rik 1.31 22.86 < 0.001 0.99 < 0.001 72.98 —
8 Slc25a18 2.25 23.78 < 0.001 0.98 < 0.001 72.8 SLC25A18
9 2810410P22Rik 1.84 19.75 < 0.001 0.98 < 0.001 71.23 —
10 Pla2g4b 0.43 11.35 < 0.001 0.98 < 0.001 70.12 PLA2G4B
11 Gfer 0.66 14.77 < 0.001 0.98 < 0.001 68.74 GFER
12 Cops8 –2.91 –21.1 < 0.001 –0.98 < 0.001 67.93 COPS8
13 Adamts9 0.85 15.38 < 0.001 0.98 < 0.001 67.84 ADAMTS9
14 Eme2 –1.74 –20.75 < 0.001 –0.98 < 0.001 68 EME2
15 C920004C08Rik –0.98 –16.06 < 0.001 –0.98 < 0.001 66.72 —
16 Slc39a9 0.65 12.83 < 0.001 0.97 < 0.001 66.17 SLC39A9
17 Arrdc3 2.07 16.82 < 0.001 0.97 < 0.001 68.47 ARRDC3
18 2810423A18Rik 1.51 17.65 < 0.001 0.97 < 0.001 68.02 —
19 Mad 1.21 17.31 < 0.001 0.97 < 0.001 68.05 —
20 A330021E22Rik 1.28 16.43 < 0.001 0.97 < 0.001 64.42 C7orf63
21 Arl5a 1.7 16.24 < 0.001 0.97 < 0.001 66.31 ARL5A
22 LOC229810 –1.64 –18.56 < 0.001 –0.97 < 0.001 68.29 —
23 Zap3-pending 0.58 13.07 < 0.001 0.97 < 0.001 65.62 —
24 Clstn1 –1.51 –18.54 < 0.001 –0.97 < 0.001 66.34 CLSTN1
26 Vrk1 0.85 –13.51 < 0.001 0.96 < 0.001 62.83 VRK1
27 2310002B06Rik –0.6 –12.66 < 0.001 –0.96 < 0.001 61.92 —
28 Polr3f –0.38 –9.54 < 0.001 –0.96 < 0.001 61.86 POLR3F
29 Gpr19 0.81 11.99 < 0.001 0.96 < 0.001 62.33 GPR19
30 Mid1 1.61 17.27 < 0.001 0.96 < 0.001 62.82 MID1
31 A630064P09Rik –0.46 –10.17 < 0.001 –0.96 < 0.001 59.67 —
32 Ccl27 –1.79 –15.52 < 0.001 –0.96 < 0.001 60.68 —
33 8430432M10Rik 0.67 11.92 < 0.001 0.95 < 0.001 59.82 —
34 Ndufb10 1.09 15.91 < 0.001 0.95 < 0.001 59.86 NDUFB10
35 Ube2i –1.04 –12.22 < 0.001 –0.95 < 0.001 56.05 UBE2I
36 Tubgcp4 0.62 10.28 < 0.001 0.95 < 0.001 55.84 TUBGCP4
37 Bub1b 0.36 8.56 < 0.001 0.94 < 0.001 53.49 BUB1B
38 Ehd4 0.67 9.79 < 0.001 0.94 < 0.001 54.66 EHD4
39 Rps2 –0.51 –10.47 < 0.001 –0.94 < 0.001 53.67 RPS2
40 Arhgap12 1.12 11.84 < 0.001 0.94 < 0.001 53.33 ARHGAP12
logFC = fold change on log2 scale between wild-type and Rasgrf2–/–; MM = module membership; kWithin = number of connections between a gene and 
other genes in a module.
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Fig. 2: Manhattan and regional association plot for the M5 (green) module associations with male adolescent binge drinking from the IMAGEN 
study sample. (A) Genome-wide association study signals for binge drinking in male adolescents. The single-nucleotide polymorphism (SNP) 
with the lowest –log(p) located within 100 kb either upstream or downstream was used to present each gene. In total 372 813 variants were 
used and 16 449 genes were mapped for enrichment analysis. (B) Regional association of the EHD4 gene locus for binge drinking in male ad-
olescents. Association p values (–log10 scale, Y axis) of variants are shown according to their chromosomal positions (X axis). Blue lines indi-
cate the genetic recombination rate (cM/Mb).
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haplotype block 3 and EHD4 mRNA expression (pempirical < 
0.001), indicating this haplotype exerts a cis­acting effect.
Discussion
Previous characterization of male Rasgrf2–/– mice revealed sig nifi­
cant reductions in ethanol intake and preference relative to wild­
type controls as well as altered mesolimbic dopamine neur on ac­
tivity and dopamine release in the NAcc.10 In the present study 
we therefore applied a systems biology approach to elucidate 
the downstream consequences of altered mesolimbic dopamine 
signalling in the NAcc of this same mouse model. We con­
structed a coexpression network using transcriptome­wide data 
derived from the NAcc of male Rasgr2–/– mice and wild­type con­
trols, which revealed 37 distinct modules of functionally related 
genes. One of these modules, M5 green, was significantly associ­
ated with both Rasgrf2 KO status (binomial trait) and Rasgrf2 
mRNA expression levels (quantitative trait), thereby highlight­
ing this module as a putative central regulator of mesolimbic do­
pamine signalling and reinforcement mechanisms in the NAcc.
Initial characterization of this module by GO term enrichment 
analysis indicated that this module plays a role in the regulation 
of protein phosphorylation and kinase activity, which is in keep­
ing with the known function of Rasgrf2 as a guanine nucleotide­
releasing factor and activator of MAP kin ase signalling path­
ways.11,24,27 We also found significant coexpression of our M5 
module genes with neuronal marker genes indicating that the 
functioning of this module is largely neuron­specific. Again, this 
is in accordance with previous  research showing that Rasgrf2 ex­
pression in the CNS is localized to neurons only, not glia.11,24 
This apparent neuron­ specific expression of M5 module genes is 
potentially interesting considering the relatively homogeneous 
neuronal make­up of the NAcc, whereby approximately 90% of 
these neurons belong to the class of medium­sized spiny neur­
ons (MSNs).6 They are known to play a critical role in the regu­
lation of alcohol reinforcement by functioning as integrators of 
dopaminergic and glutamatergic signals,28 so a neuron­ specific 
role for the M5 module in the NAcc is highly suggestive of an 
important role for this module in alcohol reinforcement mech­
anisms. Further research to determine whether M5 module 
Table 2: Summary of mouse genes in the M5 module with high module membership and gene significance (correlated with Rasgrf2 
expression levels) and their corresponding genetic association with binge drinking in humans. 
Mouse gene expression Human genetic association
Wild-type v. Rasgrf2–/– Rasgrf2 expression Binge drinking
Mouse gene MM FC p value r p value Human gene n SNP* p value
Ehd4 0.94 0.67 < 0.001 0.71 < 0.001 EHD4 30 rs1648821 < 0.001
Klc1 0.77 0.78 < 0.001 0.64 0.004 KLC1 10 rs861550 0.009
Slc5a5 0.74 1.23 < 0.001 0.66 0.003 SLC5A5 6 rs7508025 0.011
Capn3 0.66 0.17 0.006 0.67 0.002 CAPN3 9 rs4924675 0.017
Dcp1b 0.83 0.58 < 0.001 0.61 0.008 DCP1B 16 rs972657 0.022
Snapc3 0.82 0.38 < 0.001 0.62 0.006 SNAPC3 10 rs6474915 0.023
Emp2 0.79 0.44 < 0.001 0.59 0.009 EMP2 30 rs6498070 0.024
Lypd6b 0.79 0.39 < 0.001 0.60 0.008 LYPD6B 49 rs10490383 0.026
Ccl17 0.63 0.35 0.004 0.60 0.008 CCL17 8 rs4784805 0.026
Snapc1 0.81 0.42 < 0.001 0.63 0.005 SNAPC1 8 rs7143626 0.036
Adamts9 0.98 0.85 < 0.001 0.61 0.007 ADAMTS9 67 rs6793277 0.037
Gpr176 0.73 0.32 < 0.001 0.63 0.005 GPR176 26 rs17646847 0.045
Map4k5 0.83 0.23 < 0.001 0.64 0.004 MAP4K5 20 rs12881869 0.049
Neo1 0.93 0.61 < 0.001 0.63 0.005 NEO1 30 rs4132535 0.06
Pgpep1 0.85 0.45 < 0.001 0.61 0.008 PGPEP1 11 rs1978423 0.09
Pbx4 0.67 0.24 0.003 0.65 0.003 PBX4 7 rs12610185 0.11
Rnd3 0.92 0.89 < 0.001 0.63 0.005 RND3 12 rs1528429 0.12
Zfp609 0.73 0.14 0.005 0.61 0.008 ZNF609 10 rs547818 0.12
Polr3k 0.81 0.28 < 0.001 0.76 < 0.001 POLR3K 5 rs216600 0.13
A330021E22Rik 0.97 1.28 < 0.001 0.60 0.008 C7orf63 15 rs11563435 0.17
Tmco5 0.75 0.18 0.002 0.69 0.002 TMCO5A 5 rs1604528 0.19
2410076I21Rik 0.79 0.26 < 0.001 0.62 0.006 C15orf60 13 rs7176074 0.24
Lrrc57 0.99 2.44 < 0.001 0.61 0.007 LRRC57 1 rs10851410 0.50
Tubgcp4 0.95 0.62 < 0.001 0.70 0.001 TUBGCP4 3 rs2412780 0.53
Itgb3bp 0.88 0.61 < 0.001 0.74 < 0.001 ITGB3BP 9 rs3790867 0.54
Dguok 0.83 0.38 < 0.001 0.62 0.006 DGUOK 9 rs13411881 0.56
Xkr8 0.72 0.35 < 0.001 0.63 0.005 XKR8 6 rs4908382 0.74
Arl5a 0.97 1.70 < 0.001 0.64 0.004 ARL5A 2 rs10182533 0.78
FC = fold change on log2 scale between wild-type and Rasgrf2–/– mice; MM = module membership; SNP = single-nucleotide polymorphism. 
*SNP with the lowest p value (best SNP) for the gene. 
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genes influence the activity of the DARPP­32 pathway, a major 
regulator of synaptic plasticity in response to alcohol in MSNs, 
may prove informative in the elucidation of this role.28
Additional characterization of the M5 module revealed an 
enrichment of genes residing within previously identified QTL 
for alcohol preference in a recombinant mouse strain.26 Further­
more, we also found an enrichment of GWAS signals for binge 
drinking originating from M5 orthologous human genes in a 
human sample consisting of adolescent boys, indicating that 
this module, initially identified in mice, is indeed translatable to 
humans. After filtering these human orthologues to identify 
those genes representing central regulators of the M5 module 
(i.e., high module membership and a highly significant correla­
tion with Rasgrf2 mRNA expression), we highlighted 28 genes 
that represent highly convin cing candidates for a role in the 
regulation of reinforcement mechanisms in MSNs.
A literature search revealed that several of these 28 candi­
dates have previously been implicated in alcohol­ and 
 addiction­related phenotypes, thereby providing proof of prin­
ciple. For example, Snapc3 was identified as a candidate in­
volved in ethanol consumption and withdrawal in a recent QTL 
study using a recombinant panel of BxD mice.29 Snapc3 encodes 
a component of the small nuclear RNA (snRNA) activating 
complex required for the transcription of both RNA polymerase 
II and III snRNA genes.30 Interestingly, our list of 28 genes also 
contains Snapc1, which encodes another component of this com­
plex potentially highlighting snRNA as an important class of 
molecules in the regulation of reinforcement. In addition, Rnd3, 
which encodes the GTPase RhoE, has previously been impli­
cated in an astroglial inflammatory response to ethanol admin­
istration,31 whereas another gene, Klc1, has been implicated in 
morphine­induced conditioned place preference in mice.32 Inter­
estingly, Klc1 encodes kinesin chain light 1, a component of 
 kinesin motor proteins responsible for intracellular molecule 
trafficking,33 which in the context of reinforcement may play a 
role in the transport of proteins regulating synaptic plasticity.
Our list of 28 genes also includes numerous novel candidates 
that warrant further validation and characterization. Indeed, 
the most highly significant association with binge drinking 
from this list originated from the EHD4 gene, which encodes 
the ets­homology (EH) domain containing 4 protein,34 whereby 
the minor T allele of rs1648821 was associated with a higher fre­
quency of binge drinking. Extended characterization of this sin­
gle SNP association in our sample of adolescent boys revealed a 
6­marker haplotype featuring rs1648821, which not only ap­
pears to influence peripheral mRNA expression levels of 
Fig. 3: Whole brain analysis of reward anticipation and reward feedback in male adolescents from the IMAGEN study sample. Posi-
tive blood oxygen level–dependent response during (A) reward anticipation and (B) reward feedback (family-wise error–corrected 
p < 0.05). The locations of the left and right ventral striatal regions of interest (Montreal Neurological Institute coordinates: x, y, z = 
±15, 9, –9; radius = 9 mm) are depicted in green and purple, respectively.
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EHD4, but also exhibits a highly significant association with 
binge drinking. In addition, this haplotype was also associated 
with altered ventral striatal activity during the reward anticipa­
tion phase of the MID task, indicating that EHD4 may influence 
binge drinking by regulating reward and reinforcement mech­
anisms in the NAcc. This is concordant with the earlier pro­
posed idea that M5 module genes identified in mice may influ­
ence alcohol­ related phenotypes by altering reinforcement 
mechanisms in MSNs of the NAcc.
The primary function of EHD4 is in the regulation of endo­
cytosis, a process by which a small portion of plasma mem­
brane, including receptors or receptor­ligand complexes, be­
comes internalized into the cell and packaged into early 
endosomes for either degradation or recycling.35 A well­ 
characterized member of the EH domain­containing family 
of genes, EHD1, has been shown to regulate the recycling of 
AMPA receptor subunits to the plasma membrane during 
NMDA receptor–dependent LTP,35,36 a process known to be 
vital in the promotion of synaptic plasticity underlying alco­
hol reinforcement in the NAcc.37 Considering the high levels 
of homology between EHD1 and EHD4, as well as the ten­
dency of their encoded proteins to form functional heterodi­
mers,34,38 EHD4 may be involved in alcohol reinforcement 
mechanisms through the regulation of synaptic plasticity.
Limitations
The major potential limitation of the present study relates to 
the difficulty in determining the extent to which the M5 mod­
ule was dysregulated in Rasgrf2–/– mice by perturbed mesolim­
bic dopamine signalling or by the loss of Rasgrf2 function in 
the NAcc. However, our follow­up validation studies investi­
gating genetic associations between M5 module orthologues 
and binge drinking in male adolescents support a role for this 
module in the regulation of alcohol­related phenotypes, 
which suggests that the M5 module dysregulation observed 
in mutant mice was most likely a result of altered mesolimbic 
dopamine functioning. Furthermore, it should be noted that 
the findings from our coexpression network analyses in mice 
are merely correlational, so the cause–effect relationship be­
tween the M5 module and alcohol­related phenotypes cannot 
be determined on the basis of these data alone. However, 
given that this module is significantly enriched with GWAS 
signals for binge drinking episodes in a sample of adolescent 
males, this implies the M5 module — or at least certain com­
ponents of it — may regulate binge drinking in humans.
Conclusion
By means of a translational systems approach using gene ex­
pression data from the NAcc of Rasgrf2–/– mice, we have identi­
fied a module of coexpressed genes whose human orthologues 
are significantly enriched with GWAS signals for frequency of 
binge drinking in adolescent boys. We propose that these 
genes represent novel candidates for a role in the regulation of 
binge drinking and other alcohol­related phenotypes, and we 
have highlighted EHD4 as a particularly prominent candidate. 
Overall, our findings support both the validity and necessity of 
functional characterization of GWAS signals using animal 
models, as well as the translational benefits of applying sys­
tems biology approaches to these models as a means to gener­
ate additional candidate genes in humans. Considering that 
binge drinking and excessive alcohol use during adolescence 
are major contributors toward the development of alcohol 
abuse in later life, EHD4 and its associated M5 module genes 
may have predictive value with the potential to inform future 
preventative meas ures for alcohol problems in later life.
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